Clinical trial
Safety and Efficacy of CryoCor™ Cryoablation for PAF
NCT00231296 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00231296 |
|---|---|
| Title | Safety and Efficacy of CryoCor™ Cryoablation for PAF |
| Official title | A Clinical Study to Evaluate the Safety and Efficacy of the CryoCor(TM)Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device, Drug |
| Interventions | Cardiac CryoCor Cryoablation System, Medical management |
| Enrollment | 174 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 4, 2005 |
| Last update posted | May 4, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: